Stockreport

Omeros Submits its Biologics License Application to U.S. FDA for Narsoplimab in HSCT-TMA

Omeros Corporation  (OMER) 
Last omeros corporation earnings: 3/2 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.omeros.com
PDF -- Priority Review Requested -- SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) announced that it has completed the rolling submission of its Biologics Li [Read more]